In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea's Health Ministry To Unveil Steeper Price Cuts After Patent Loss; Generics Could Be The Big Loser

This article was originally published in The Pink Sheet Daily

Executive Summary

Price cuts that level the cost between generics and off-patent originals would deal another heavy blow to the local pharma industry, which relies primarily on generic sales.
Advertisement

Related Content

South Korea's Health Ministry Unveils Provisions For November's Anti-rebate Law
South Korea's Health Ministry Unveils Provisions For November's Anti-rebate Law

Topics

Advertisement
UsernamePublicRestriction

Register

PS072533

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel